A phase 1b/2 study of INCB039110+nab-paclitaxel (N) and gemcitabine (G) in patients (pts) with advanced solid tumors and pancreatic cancer (PC).

被引：4

作者：

Beatty, Gregory Lawrence

Shanda, Safi

Beck, J. Thaddeus

Uppal, Nikhil Premparkash

Cohen, Steven J.

Donehower, Ross C.

Gabayan, A. Eli

Assad, Albert

Switzky, Julie C.

Zhen, Huiling

Von Hoff, Daniel D.

机构：

[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA

[2] Indiana Univ, Indianapolis, IN 46204 USA

[3] Highlands Oncol Grp, Fayetteville, AR USA

[4] Arena Onc Assoc, New York, NY USA

[5] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[6] Johns Hopkins Canc Ctr, Baltimore, MD USA

[7] Beverly Hills Canc Ctr, Beverly Hills, CA USA

[8] Incyte Corp, Wilmington, DE USA

[9] Translat Genom Res Inst TGen, Phoenix, AZ USA

[10] HonorHealth, Scottsdale, AZ USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.4_suppl.362

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

362

引用

页数：1